June 29, 2017

Ricerca Biosciences Renamed To Concord Biosciences After Sale Of Chemical Development Division

After the sale of its Chemical Development division to Olon S.p.A., Ricerca Biosciences is being renamed Concord Biosciences. Concord Biosciences is an experienced CRO with emphasis on active pharmaceutical and non-pharmaceutical ingredient safety and metabolism, bioanalytical, and agrochemical research.

Read More  >